Trinity Biotech (TRIB) announced that the Company welcomes the indicated intention of its largest investor and primary lender, Perceptive Advisors, to submit a proposal that, if implemented, would facilitate the conversion of a portion of the Company’s outstanding debt and other obligations into equity. The Company believes this strategic initiative represents a constructive step toward strengthening its balance sheet and that an equitization program, if successfully executed, could enhance the Company’s financial flexibility and support its ambitious growth objectives.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech Amends Constitution and Credit Agreement Following AGM
- Trinity Biotech Announces AGM Results and Board Changes
- Trinity Biotech Releases 2024 Annual Report
- Trinity Biotech Regains Nasdaq Compliance as of September 2025
- Trinity Biotech regains compliance with Nasdaq listing requirements